A case report of individualized treatment of high risk and volume metastatic prostate cancer / 中华泌尿外科杂志
Chinese Journal of Urology
; (12): 19-23, 2021.
Article
in Zh
| WPRIM
| ID: wpr-911167
Responsible library:
WPRO
ABSTRACT
A 69-year old man presented with high-risk metastatic prostate cancer. After 7 months of androgen deprivation therapy (ADT), he progressed to metastatic castration resistant prostate cancer. We suggested him comprehensive therapy, including Abiraterone, chemo-therapy, radio-therapy, platinum chemo-therapy and Enzalutamide, which proved effective with his long term survival.
Full text:
1
Index:
WPRIM
Type of study:
Etiology_studies
Language:
Zh
Journal:
Chinese Journal of Urology
Year:
2021
Type:
Article